Search
Sumario de resultados
TIpos de contenido
Fecha
-
NewBCN HEALTH publishes a study evaluating the incidence and medical costs associated to pneu...
BCN HEALTH conducted a retrospective study based on the records of patients hospitalized due to pneumococcal disease and treated in Spanish public and private hospitals between January of 2008 and
-
NewYsios Capital’s portfolio company Aura Biosciences prices IPO on NASDAQ
Aura Biosciences, Inc. is a clinical-stage oncology company developing a novel technology platform based on virus-like drug conjugates (VDCs) to target and destroy cancer cells selectively while
-
NewMore than 1,750 students participate in the 2nd edition launch of “Reimagine Science”
More than 1,750 young high school students from all over Catalonia participate in the launch of the second edition of “Reimagine Science: clinical trials, research and drug development” programme by
-
EventBiotech Showcase Digital 2022
The event will be delivered digitally January 10–12, 2022 and January 17–19, 2022 on partneringONE®.
-
NewCommercial Adoption of Herdscreen® ASFV Antibody Test in Europe
New pen-side test allows for highly specific, sensitive detection of infected animals or contaminated pig-derived products
-
NewArchivel Farma is proud to announce the recruitment of the first patient in the STriTuVaD ...
The clinical trials will be conducted in two centers in India: the All India Institute Of Medical Sciences (AIIMS) of New Delhi, and the Agartala Government Medical College of Agartala
-
NewAsphalion launches CTIS support and training programme
CTIS will be the single entry point for submitting clinical trial information in the EU
-
NewBCN HEALTH presents three communications in the congress ISPOR Europe based on retrospecti...
The objectives of the study were to describe patient characteristics, calculate hospital incidence and mortality associated with Alzheimer's disease in Spain, and assess direct medical costs at
-
NewA study we co-authored out today in JAMA Pediatrics supports the widespread adoption and i...
Study population mirrors diversity of US demographics and findings demonstrate that whole genome sequencing should be considered a first-line test for patients with suspected genetic disease
-
NewORYZON enrolls first patient in the US in PORTICO, a Phase IIb clinical trial with vafide...
PORTICO already recruiting in several European countries
-
EventWhy WE Lead Food?
-
CompanySANOFI
-
NewReport | Genomic analysis, nanoencapsulation and microbiological quality control: three ke...
We spoke with our members about the future of these precision techniques on a scale that is nearly invisible to the human eye, their current applications and the roadblocks to implementing them
-
NewORYZON presents safety and efficacy data of vafidemstat from the Phase II SATEEN trial in...
Long-term vafidemstat treatment was safe and well tolerated with drug exposures up to 2 years Anti-inflammatory activity observed in vafidemstat-treated patients SATEEN was a pilot, small scale, trial
-
NewFlomics Biotech, finalist in the Global Startup Awards
The company has focused on the study of circulating RNA for the early detection of cancer
-
NewBCN HEALTH publishes a study evaluating the incidence and medical cost associated to intra...
The company conducted a retrospective study based on the records of patients hospitalized due to intrahepatic cholangiocarcinoma (iCCA) and treated in Spanish public and private hospitals between
-
NewMerck works to implement Syntropy in Spain, an innovative artificial intelligence project ...
The aim is to provide scientists and research centres with leading technology for data integration and analysis, while ensuring data control, ownership, and traceability
-
NewSetting up a biotech firm as a woman and a scientist
A new SEBBM group is looking to help researchers take their ideas to market through a sharing space
-
-
Press releaseBiotechnology from around the world comes together in BIOSPAIN 2021 to promote collaborati...
The President of Navarra, María Chivite, has described this sector as strategic for economic recovery and with great potential for job creation. This international benchmark event, organised by AseBio
-
Press releaseThe Minister of Science and Innovation, Diana Morant, emphasised that biotechnology drives...
The Regional Minister for Economic and Business Development, Mikel Irujo, underlines Navarre's leadership and highlights the importance of BIOSPAIN in promoting relations between Navarrese companies